These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 15447749)
21. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care. Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537 [TBL] [Abstract][Full Text] [Related]
22. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788 [TBL] [Abstract][Full Text] [Related]
23. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies. Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075 [TBL] [Abstract][Full Text] [Related]
24. Gastric acidity in patients with follicular gastritis is significantly reduced, but can be normalized after eradication for Helicobacter pylori. Shimatani T; Inoue M; Iwamoto K; Hyogo H; Yokozaki M; Saeki T; Tazuma S; Horikawa Y; Harada N Helicobacter; 2005 Jun; 10(3):256-65. PubMed ID: 15904484 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers. Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036 [TBL] [Abstract][Full Text] [Related]
26. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference. Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345 [TBL] [Abstract][Full Text] [Related]
27. Serum gastrin concentration and changes in G and D cell densities in gastric antrum in children with chronic gastritis. Czaja M; Szarszewski A; Kamińska B; Bogotko-Szarszewska M; Luczak G; Kozielska E; Delińska-Galińska A; Korzon M Int J Clin Pract; 2008 Jul; 62(7):1044-9. PubMed ID: 17573842 [TBL] [Abstract][Full Text] [Related]
29. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799 [TBL] [Abstract][Full Text] [Related]
30. Is GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children? Koivusalo AI; Pakarinen MP; Kolho KL Diagn Microbiol Infect Dis; 2007 Jan; 57(1):35-8. PubMed ID: 16949782 [TBL] [Abstract][Full Text] [Related]
31. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254 [TBL] [Abstract][Full Text] [Related]
32. The non-invasive diagnosis of precancerous changes of stomach mucosa. Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316 [TBL] [Abstract][Full Text] [Related]
33. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. de Angelis GL; Cavallaro LG; Maffini V; Moussa AM; Fornaroli F; Liatopoulou S; Bizzarri B; Merli R; Comparato G; Caruana P; Cavestro GM; Franzé A; Di Mario F Dig Dis; 2007; 25(3):206-13. PubMed ID: 17827941 [TBL] [Abstract][Full Text] [Related]
34. Extreme hypergastrinemia caused by atrophic gastritis and Helicobacter pylori infection--a case report. Huang SM; Lin HH; Wen TY; Hsu YH Hepatogastroenterology; 2001; 48(40):1215-6. PubMed ID: 11490838 [TBL] [Abstract][Full Text] [Related]
35. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis. Kim EH; Kang H; Park CH; Choi HS; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884 [TBL] [Abstract][Full Text] [Related]
36. Using serum pepsinogens wisely in a clinical practice. Miki K; Urita Y J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129 [TBL] [Abstract][Full Text] [Related]
37. Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Satoh K; Kimura K; Taniguchi Y; Yoshida Y; Kihira K; Takimoto T; Kawata H; Saifuku K; Ido K; Takemoto T; Ota Y; Tada M; Karita M; Sakaki N; Hoshihara Y Am J Gastroenterol; 1996 May; 91(5):963-9. PubMed ID: 8633589 [TBL] [Abstract][Full Text] [Related]
38. Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese. Zhang Z; Sun Lp; Gong YH; Wang XG; Zhang M; Yuan Y J Dig Dis; 2007 May; 8(2):72-6. PubMed ID: 17532818 [TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study. Matsuhisa T; Miki M; Yamada N; Sharma SK; Shrestha BM Kathmandu Univ Med J (KUMJ); 2007; 5(3):295-301. PubMed ID: 18604043 [TBL] [Abstract][Full Text] [Related]
40. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies. Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]